Show simple item record

dc.contributor.authorLau, Kristin
dc.date.accessioned2012-05-25T17:25:02Z
dc.date.available2012-05-25T17:25:02Z
dc.date.issued2012-04-11
dc.identifier.urihttps://hdl.handle.net/1813/28974
dc.description.abstractMultiple myeloma is responsible for approximately eight percent of all canine hematopoietic tumors and is accountable for 3.6 percent of all neoplasias affecting the bones of dogs. It is a neoplasia of the plasma cells in the bone marrow. Classically, diagnosis of canine multiple myeloma is made based on the presence at least two of the following four criteria: 1) bone marrow plasmacytosis of greater than five percent, 2) radiographic evidence of osteolysis, 3) monoclonal gammopathy on serum or urine electrophoresis, and 4) Bence-jones proteinuria. Many of the clinical signs and complications associated with multiple myeloma are caused by the overproduction of the M component (immunoglobulins) by neoplastic plasma cells. In dogs, the immunoglobulins produced excessively are IgG, IgA, and IgM (macroglobulinemia). If there is only abnormal over-production of the immunoglobulin light chains, Bence-jones proteinuria is observed. In rare cases, such as a nonsecreting multiple myeloma, some of the criteria for diagnosis may be absent. Diagnosis is then made by the extent of bone marrow plasmacytosis and the presence of neoplastic plasma cells.en_US
dc.language.isoen_USen_US
dc.relation.ispartofseriesSenior seminar paper
dc.relation.ispartofseriesSeminar SF610.1 2012
dc.subjectDogs -- Diseases -- Case studiesen_US
dc.titleMultiple myeloma in a six year old Labrador Retrieveren_US
dc.typeterm paperen_US


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Statistics